The global genitourinary drugs market is accounted for USD 28,200 million expected and expected to register CAGR ~1.65% during the forecast period (2018–2023).
Genitourinary disorders are caused by damage to urinal or genital part of the human body. Kidney, bladder, ureter and urethra are parts of genitourinary system, genitourinary drugs are used to treat the medical complications caused to these parts. The rising prevalence of genitourinary disorders, increasing number of pipeline drugs, and technological advancement in genitourinary diagnosis are expected to drive the growth of the market. According to the U.S. National Library of Medicine more than 480 clinical trials are lined up for treatment of urinary tract infection.
Health Information Center, Moreover, rising R&D spending and collaborative strategies adopted by the top players such as licensing and agreements are contributing to the growth of the market. For instance, in October 2018, Novartis AG signed a licensing agreement with Boston Pharmaceuticals for manufacturing and marketing of its three anti-infective products LYS228, IID572, and MAK181.
The increasing emergence of counterfeit drugs, rising generics drug competition, and high number of patent expirations may hamper the growth of the market during the assessment period.
Segmentation
The global genitourinary drugs market has been segmented on the basis of disease, product, and end-user.
On the basis of disease, the market has been classified urinary tract infections, erectile dysfunction, urinary incontinence & overactive bladder, kidney/renal cancer, genitourinary cancer, bladder cancer, bladder cancer, cervical cancer, sexually transmitted diseases, interstitial cystitis, hematuria, ovarian cancer, prostate cancer, and others.
The product segment has been divided into urologicals, hormonal therapy, gynecologicals, and anti-infectives.
The market, by end-user, has been segmented into hospitals, clinics, super specialty centers, and others.
Global Genitourinary Drugs Market, by Disease
- Urinary Tract Infections
- Urinary Incontinence & Overactive Bladder
- Kidney/Renal Cancer
- Genitourinary Cancer
- Bladder Cancer
- Cervical Cancer
- Sexually Transmitted Diseases
- Interstitial Cystitis
- Hematuria
- Ovarian Cancer
- Prostate Cancer
- Others
Global Genitourinary Drugs Market, by Product
- Urologicals
- Hormonal Therapy
- Gynaecologicals
- Anti-Infectives
- Others
Global Genitourinary Drugs Market, by End-User
- Hospitals
- Clinics
- Super Specialty Centers
- Others
Request Customization
Get a Sample
Get a Sample
Request Customization